Skip to content
PeptideAgent

Compounding pharmacies in Vermont

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Vermont Board of Pharmacy (Office of Professional Regulation, Vermont Secretary of State) regulates compounding pharmacies in Vermont. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Vermont at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Vermont

No verified compounding pharmacies serving Vermont are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Vermont

The Vermont Board of Pharmacy, administered by the Office of Professional Regulation, licenses pharmacists and drug outlets under 26 V.S.A. chapter 36. Section 2061 requires every drug outlet to register and hold a license in one or more classifications, including retail, compounding, outsourcing, and home infusion, and the Board sets the criteria for each by rule. The Board's administrative rules effective February 1, 2026 settle both points. Rule 10-9 requires a drug outlet physically located outside Vermont but doing business in Vermont to register for the applicable license type; rule 7-4(b) requires a nonresident outlet to submit an inspection report assessing compliance with applicable law and USP standards, done by its home-state board, the national pharmacy boards association, FDA, or another recognized third party within 2 years before application for a compounding or home infusion pharmacy; and rule 6-2 requires a qualifying inspection at each renewal. Rule 10-4 requires a pharmacy that compounds to register as a compounding pharmacy in addition to its retail license and to comply with 21 U.S.C. 353a, USP chapter 795 for non-sterile compounding, USP chapter 797 for sterile compounding, and USP chapter 800 for hazardous drugs, and to compound only on a patient-specific order or in limited quantities based on regularly observed prescribing patterns. Vermont has not adopted its own list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [3] [5] [6] [7]

Compounded GLP-1 access in Vermont

A pharmacy compounding a GLP-1 for a Vermont patient must hold the appropriate Vermont drug outlet license, including a nonresident license if it ships from out of state. [1] [6] [9]

Research use only sellers in Vermont

Under 26 V.S.A. chapter 36, drugs may be dispensed to Vermont patients only by licensed pharmacists working in licensed drug outlets, so a seller shipping "research use only" injectable peptides to Vermont consumers is not a licensed outlet. [5] [10]

Vermont notes on specific peptides

  • Semaglutide: Available branded by prescription, including from a Vermont-authorized prescriber after a telemedicine or store-and-forward examination under 18 V.S.A. 9361. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [4] [9]

How to check a compounding pharmacy in Vermont

  1. Search the Vermont Board of Pharmacy (Office of Professional Regulation, Vermont Secretary of State) license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Vermont requires before it ships to you. [1] [2] [3] [5] [6] [7]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Vermont. [5] [10]

Common questions in Vermont

Does a compounding pharmacy need a Vermont license to ship to me?

Yes. 26 V.S.A. section 2061 requires every drug outlet to hold a Vermont Board of Pharmacy license in the correct classification. Under the Board's 2026 rules, an outlet outside Vermont doing business in the state must register for the applicable license type (rule 10-9), a pharmacy that compounds must also register as a compounding pharmacy (rule 10-4), and a nonresident compounding pharmacy must submit an inspection report from the prior 2 years (rule 7-4). Check the Office of Professional Regulation license lookup before ordering. [2] [3] [6]

Can a Vermont pharmacy compound peptides that are not on the FDA bulks list?

Generally no. Vermont has no state bulks list, so the federal 503A test applies: the substance must be a component of an approved drug, have a USP or NF monograph, or be on the FDA 503A bulks list. Peptides in FDA Category 2 cannot be compounded. [7] [8]

All peptide legal questions for Vermont

Sources

  1. [1]Vermont Board of Pharmacy (Office of Professional Regulation)
  2. [2]Vermont Board of Pharmacy: statutes, rules, and resources
  3. [3]Administrative Rules for the Vermont Board of Pharmacy, effective February 1, 2026 (rules 6-2, 7-4, 10-4, 10-9)
  4. [4]18 V.S.A. section 9361, Health care providers delivering health care services through telemedicine or by store-and-forward means
  5. [5]26 V.S.A. chapter 36, Pharmacy
  6. [6]26 V.S.A. section 2061, Registration and licensure of drug outlets
  7. [7]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  8. [8]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts